Why Novavax Stock Is Skyrocketing Today
Shares of Novavax (NASDAQ: NVAX) are skyrocketing today, up 59.4% as of 10:30 a.m. EDT, after the biotech announced yesterday evening that the Coalition for Epidemic Preparedness Innovations (CEPI) is investing up to $384 million of additional funding in Novavax's experimental COVID-19 vaccine. In March, CEPI provided a $4 million grant to Novavax for its novel coronavirus program.
This latest investment was definitely a huge deal for Novavax. It provides a lot of money for the biotech to move forward with clinical testing of its COVID-19 vaccine candidate NVX-CoV2373. The funding also increased the perception of Novavax as a leader in the race to develop a vaccine for the novel coronavirus.
Image source: Getty Images.
Source Fool.com
